Skip to main content
. 2021 Oct 25;8:722340. doi: 10.3389/fcvm.2021.722340

Table 3.

Table for metabolic therapy.

Novel therapies Targets Mechanisms
Perhexiline CPT1/2 shifting LCFA→ glucose
Mavacamten β-myosin heavy chain stabilizes the super relaxed state
Omecamtiv mecarbil Ca2+ accelerating ATP generation